Published Date: 19 May 2026
Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.
Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.
A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.
The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.
A new global phase 2 trial, TARBELA-AD, will test RG6434, Roche's investigational oral NLRP3 inflammasome inhibitor, in adults with early symptomatic Alzheimer disease.
A pivotal phase 2/3 trial of Zhimeng Biopharma's CB03-154, an oral KCNQ2/3 potassium channel opener, has completed enrollment in amyotrophic lateral sclerosis.
1.
NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.
2.
Skinny melanoma incidence is associated with vitamin D deficiency.
3.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
4.
What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'
5.
Immunotherapy after surgery is good for patients with advanced cancer
1.
Unveiling the Complexity of Multiple Myeloma Staging
2.
Molecular Mechanisms of Tumor Extracellular-Matrix Stiffness Sensing
3.
Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer
4.
Multispecific Immune Engagers: Engineering T Cells, NK Cells and Tumor Recognition Beyond Bispecific Antibodies
5.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
Early Warning Signs of Cancer
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Tumor-Associated Fibroblast Metabolites as Biomarkers of Stromal Activity
5.
Recognizing Symptoms That May Require Cancer Evaluation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation